SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-006492
Filing Date
2019-11-14
Accepted
2019-11-14 11:52:44
Documents
3
Period of Report
2019-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 17613
2 PROMISSORY NOTE curr_ex101.htm EX-10.1 38852
3 PRESS RELEASE curr_ex991.htm EX-99.1 6490
  Complete submission text file 0001477932-19-006492.txt   64225
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 191217997
SIC: 2673 Plastics, Foil & Coated Paper Bags